0000899243-19-020819.txt : 20190801 0000899243-19-020819.hdr.sgml : 20190801 20190801160647 ACCESSION NUMBER: 0000899243-19-020819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190731 FILED AS OF DATE: 20190801 DATE AS OF CHANGE: 20190801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHROFF ZUBEEN CENTRAL INDEX KEY: 0001056630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 19992697 MAIL ADDRESS: STREET 1: C/O HALSEY DRUG CO INC STREET 2: 1827 PACIFIC STREET CITY: BROOKLYN STATE: NY ZIP: 11233 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-31 0 0001596946 Quotient Ltd QTNT 0001056630 SHROFF ZUBEEN C/O GALEN PARTNERS, 680 WASHINGTON BLVD STAMFORD CT 06901 1 0 1 0 Ordinary Shares 7329074 I See footnote Ordinary Shares 2019-07-31 4 M 0 4680 A 22156 D Ordinary Share Option (Right to Buy) 11.62 2025-10-31 Ordinary Shares 7505 7505 D Ordinary Share Option (Right to Buy) 8.00 2024-04-29 Ordinary Shares 5000 5000 D Ordinary Share Option (Right to Buy) 9.95 2024-10-31 Ordinary Shares 5025 5025 D Ordinary Share Option (Right to Buy) 5.73 2026-10-31 Ordinary Shares 8726 8726 D Ordinary Share Option (Right to Buy) 5.21 2027-10-31 Ordinary Shares 9597 9597 D Restricted Stock Units Ordinary Shares 2879 2879 D Restricted Stock Units 2019-07-31 4 M 0 4680 0.00 D Ordinary Shares 4680 4680 D Ordinary Share Option (Right to Buy) 6.41 2028-10-31 Ordinary Shares 6240 6240 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. All 7,505 options have vested and remain exercisable. All 5,000 options have vested and remain exercisable All 5,025 options have vested and remain exercisable. 5,818 options have vested and remain exercisable, 2,908 options will vest on October 31, 2019. 3,199 options vested on October 31, 2018 and remain exercisable, 3,199 options will vest on October 31, 2019 and 3,199 options will vest on October 31, 2020. On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, of which 2,879 have vested and have been exercised. The remaining 2,879 restricted stock units will vest on October 31, 2019. On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, of which 14,041 have vested and have been exercised. The remaining 4,680 restricted stock units will vest on October 31, 2019. The options vest and become exercisable in three equal annual installments beginning October 31, 2019. /s/ Zubeen Shroff 2019-08-01